ទំព័រដើម › ជំងឺធាត់ › តិចាស › San Antonio
ការសាកល្បងគ្លីនិកសម្រាប់ ជំងឺធាត់ នៅក្នុង San Antonio, TX
ការសិក្សាចំនួន 40 សម្រាប់ ជំងឺធាត់ កំពុងរកអ្នកចូលរួមនៅតាមទីតាំងក្នុង និងជុំវិញ San Antonio (ក្នុងចម្ងាយប្រហែល 30 ម៉ាយ)។ បើកការសិក្សាមួយដើម្បីមើលថាតើនរណាអាចចូលរួម និងរបៀបទំនាក់ទំនងទៅកាន់ក្រុមការងារសិក្សា។
អត្ថបទសិក្សាផ្លូវការ (អង់គ្លេស)
កំពុងរកអ្នកចូលរួមសម្រាប់ការសិក្សាមួយនៅទីនេះ? លេចធ្លោនៅផ្នែកខាងលើនៃទំព័រនេះ — $99 សម្រាប់ 30 ថ្ងៃ →
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
កំពុងជ្រើសរើសដំណាក់កាល 3
- Clinical Trials of Texas, San Antonio
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
កំពុងជ្រើសរើសដំណាក់កាល 3
- Bandera Family Health Care, San Antonio
- Consano Clinical Research - Shavano Park, Shavano Park · ឆ្ងាយ 12 ម៉ាយ
A Study to Evaluate the Impact of Renal Impairment on the Pharmacokinetics (PK) of Ribupatide
កំពុងជ្រើសរើសដំណាក់កាល 1ស្វាគមន៍អ្នកស្ម័គ្រចិត្តដែលមានសុខភាពល្អ
- Kailera Clinical Site, San Antonio
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
កំពុងជ្រើសរើសដំណាក់កាល 3
- DM Clinical, San Antonio
- The Texas Liver Institute, San Antonio
- Pinnacle Clinical Research, San Antonio
- និង 1 ទៀត
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
កំពុងជ្រើសរើសដំណាក់កាល 3
- VIP Trials, San Antonio
Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D
កំពុងជ្រើសរើសដំណាក់កាល 1
- Endeavor Clinical Trials, San Antonio
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
កំពុងជ្រើសរើសដំណាក់កាល 3
- Sleep Therapy Research Center, San Antonio
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
កំពុងជ្រើសរើសដំណាក់កាល 3
- Gastroenterology Research of San Antonio, San Antonio
- Southern Star Research Institute, San Antonio
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
កំពុងជ្រើសរើសដំណាក់កាល 3
- Gastroenterology Research of San Antonio, San Antonio
- Southern Star Research Institute, San Antonio
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
កំពុងជ្រើសរើសដំណាក់កាល 3
- IMA Clinical Research San Antonio, San Antonio
- Endeavor Clinical Trials, San Antonio
- Consano Clinical Research, LLC, Shavano Park · ឆ្ងាយ 12 ម៉ាយ
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
កំពុងជ្រើសរើសដំណាក់កាល 3
- IMA Clinical Research San Antonio, San Antonio
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
កំពុងជ្រើសរើសដំណាក់កាល 3
- VIP Trials, San Antonio
- Endeavor Clinical Trials, San Antonio
- Consano Clinical Research, LLC, Shavano Park · ឆ្ងាយ 12 ម៉ាយ
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
កំពុងជ្រើសរើសដំណាក់កាល 2
- Endeavor Clinical Trials, San Antonio
A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
កំពុងជ្រើសរើសដំណាក់កាល 3
- Sleep Therapy Research Center, San Antonio
- Consano Clinical Research, LLC, Shavano Park · ឆ្ងាយ 12 ម៉ាយ
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
កំពុងជ្រើសរើសដំណាក់កាល 3
- IMA Clinical Research San Antonio, San Antonio
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
កំពុងជ្រើសរើសដំណាក់កាល 3
- Research Site, San Antonio
- Research Site, San Antonio
- Research Site, San Antonio
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
កំពុងជ្រើសរើសដំណាក់កាល 3
- AURORA-2 Clinical Site, San Antonio
- AURORA-2 Clinical Site, San Antonio
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
កំពុងជ្រើសរើសដំណាក់កាល 3
- AURORA-1 Clinical Site, San Antonio
- AURORA-1 Clinical Site, San Antonio
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
កំពុងជ្រើសរើសដំណាក់កាល 3
- Pinnacle Clinical Research - San Antonio, San Antonio
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
កំពុងជ្រើសរើសដំណាក់កាល 2
- Consano Clinical Research, LLC, Shavano Park · ឆ្ងាយ 12 ម៉ាយ
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
កំពុងជ្រើសរើសដំណាក់កាល 3
- Pinnacle Clinical Research - South San Antonio, San Antonio
- IMA Clinical Research - San Antonio, San Antonio
- Consano Clinical Research, Shavano Park · ឆ្ងាយ 12 ម៉ាយ
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
កំពុងជ្រើសរើសដំណាក់កាល 3ស្វាគមន៍អ្នកស្ម័គ្រចិត្តដែលមានសុខភាពល្អ
- ACCOMPLISH-2 Research Site, San Antonio
- ACCOMPLISH-2 Research Site, San Antonio
AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
កំពុងជ្រើសរើសដំណាក់កាល 3
- Sleep Therapy Research Center, San Antonio
AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
កំពុងជ្រើសរើសដំណាក់កាល 3
- Sleep Therapy Research Center, San Antonio
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
កំពុងជ្រើសរើសដំណាក់កាល 2
- Consano Clinical Research, LLC, Shavano Park · ឆ្ងាយ 12 ម៉ាយ
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
កំពុងជ្រើសរើសដំណាក់កាល 2
- Endeavor Clinical Trials, San Antonio
A First-in-human Research Study on How NNC0721-8060 Works in People Living With Overweight or Obesity
កំពុងជ្រើសរើសដំណាក់កាល 1ស្វាគមន៍អ្នកស្ម័គ្រចិត្តដែលមានសុខភាពល្អ
- ICON, San Antonio
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
កំពុងជ្រើសរើសដំណាក់កាល 4
- Texas Dermatology and Laser Specialists, San Antonio
A Study of LY4174794 in Participants With Obesity or Overweight Who Are Otherwise Healthy
កំពុងជ្រើសរើសដំណាក់កាល 1ស្វាគមន៍អ្នកស្ម័គ្រចិត្តដែលមានសុខភាពល្អ
- ICON Early Phase Services, LLC, San Antonio
Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
កំពុងជ្រើសរើសដំណាក់កាល 3
- Kailera Clinical Site, San Antonio
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
កំពុងជ្រើសរើសដំណាក់កាល 3
- VIP Trials, San Antonio
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
កំពុងជ្រើសរើសដំណាក់កាល 3
- Research Site, San Antonio
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight
កំពុងជ្រើសរើសដំណាក់កាល 1ស្វាគមន៍អ្នកស្ម័គ្រចិត្តដែលមានសុខភាពល្អ
- ICON Early Phase Services, San Antonio
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
កំពុងជ្រើសរើសដំណាក់កាល 3
- University Hospital, San Antonio
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
កំពុងជ្រើសរើសដំណាក់កាល 3
- ACCOMPLISH-1 Research Site, San Antonio
A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia
កំពុងជ្រើសរើសដំណាក់កាល 2
- Flourish Research - San Antonio Medical Trials, San Antonio
- Endeavor Clinical Trials, San Antonio
- Consano Clinical Research, LLC, Shavano Park · ឆ្ងាយ 12 ម៉ាយ
A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
កំពុងជ្រើសរើសដំណាក់កាល 3
- VIP Trials_San Antonio, San Antonio
Modifying Adiposity Through Behavioral Strategies to Improve COVID-19 Rehabilitation
កំពុងជ្រើសរើសស្វាគមន៍អ្នកស្ម័គ្រចិត្តដែលមានសុខភាពល្អ
- South Texas Health Care System, San Antonio, TX, San Antonio
A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1R Agonist Use
កំពុងជ្រើសរើសដំណាក់កាល 3ស្វាគមន៍អ្នកស្ម័គ្រចិត្តដែលមានសុខភាពល្អ
- Vanda Investigational Site, San Antonio
Effects of Tirzepatide on Muscle and Vascular Health in Obese Older Adults
កំពុងជ្រើសរើសដំណាក់កាល 2
- University of Texas Health Science Center at San Antonio, San Antonio
ការសាកល្បងសម្រាប់ ជំងឺធាត់ នៅក្នុងទីក្រុងផ្សេងទៀត
- Houston, TXការសិក្សា 43
- Chicago, ILការសិក្សា 41
- New York City, NYការសិក្សា 40
- Washington, DCការសិក្សា 33
- Orlando, FLការសិក្សា 32
- Dallas, TXការសិក្សា 30
- Boston, MAការសិក្សា 28
- Las Vegas, NVការសិក្សា 27
- Miami, FLការសិក្សា 27
- Baltimore, MDការសិក្សា 26
- Jacksonville, FLការសិក្សា 25
- St. Louis, MOការសិក្សា 25
ការសិក្សាផ្សេងទៀតនៅក្នុង San Antonio
- Non-Small Cell Lung Cancerការសិក្សា 59
- មហារីកទ្រូងការសិក្សា 47
- មហារីកពោះវៀនធំ និងទ្វារមាសការសិក្សា 46
- មហារីកដែលរីករាលដាលការសិក្សា 44
- មហារីក (គ្រប់ប្រភេទ)ការសិក្សា 41
- ជំងឺទឹកនោមផ្អែមប្រភេទ ២ការសិក្សា 37
- ទម្ងន់លើសការសិក្សា 34
- មហារីកស៊ុតការសិក្សា 31
- មហារីកតំបក់ការសិក្សា 31
- មហារីកតូចការសិក្សា 28
- មហារីកស្រទាប់ស្បែកស្តីការសិក្សា 27
- មហារីកសួតការសិក្សា 26
ពី ClinicalTrials.gov, ទិន្នន័យទទួលបាននៅថ្ងៃ 6 តុលា 2026។ ការសិក្នានីមួយៗកំណត់លក្ខខណ្ឌលក្ខណៈសម្បត្តិរបស់ខ្លួន; ក្រុមការងារសិក្សាកំណត់ថាតើនរណាអាចចូលរួម។